The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Cohort
2.2. Predictor and Outcome Variables and Co-Variates
2.3. Statistical Analysis
3. Results
3.1. Participant Characteristics
3.2. Primary Analysis: Univariable and Multivariable Regression
3.3. Secondary Analyses: Interactions Analysis
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
BMI | Body mass index |
CAP | Controlled attenuation parameter |
DM | Diabetes mellitus |
HLD | Hyperlipidemia |
HTN | Hypertension |
MASLD | Metabolic dysfunction-associated steatotic liver disease |
NHANES | National Health and Nutrition Examination Survey |
SDOH | Social determinants of health |
US | United States |
References
- Younossi, Z.M.; Golabi, P.; Paik, J.M.; Henry, A.; Van Dongen, C.; Henry, L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 2023, 77, 1335–1347. [Google Scholar] [CrossRef]
- Giammarino, A.M.; Qiu, H.; Bulsara, K.; Khan, S.; Jiang, Y.; Da, B.L.; Bernstein, D.E.; Satapathy, S.K. Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis. Hepatol. Commun. 2022, 6, 550–560. [Google Scholar] [CrossRef] [PubMed]
- Li, W.; Kemos, P.; Salciccioli, J.D.; Marshall, D.C.; Shalhoub, J.; Alazawi, W. Socioeconomic Factors Associated With Liver-Related Mortality From 1985 to 2015 in 36 Developed Countries. Clin. Gastroenterol. Hepatol. 2021, 19, 1698–1707.e1613. [Google Scholar] [CrossRef]
- Office of Disease Prevention and Health Promotion (ODPHP). Healthy People 2030: Social Determinants of Health. Available online: https://odphp.health.gov/healthypeople/priority-areas/social-determinants-health (accessed on 21 April 2025).
- Gepner, Y.; Shelef, I.; Komy, O.; Cohen, N.; Schwarzfuchs, D.; Bril, N.; Rein, M.; Serfaty, D.; Kenigsbuch, S.; Zelicha, H.; et al. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J. Hepatol. 2019, 71, 379–388. [Google Scholar] [CrossRef] [PubMed]
- Reginato, E.; Pippi, R.; Aiello, C.; Sbroma Tomaro, E.; Ranucci, C.; Buratta, L.; Bini, V.; Marchesini, G.; De Feo, P.; Fanelli, C. Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes. J. Clin. Med. 2019, 8, 851. [Google Scholar] [CrossRef]
- Rajewski, P.; Cieściński, J.; Rajewski, P.; Suwała, S.; Rajewska, A.; Potasz, M. Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease. Biomedicines 2025, 13, 217. [Google Scholar] [CrossRef]
- Karlas, T.; Petroff, D.; Sasso, M.; Fan, J.-G.; Mi, Y.-Q.; de Lédinghen, V.; Kumar, M.; Lupsor-Platon, M.; Han, K.-H.; Cardoso, A.C.; et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J. Hepatol. 2017, 66, 1022–1030. [Google Scholar] [CrossRef]
- Rinella, M.E.; Lazarus, J.V.; Ratziu, V.; Francque, S.M.; Sanyal, A.J.; Kanwal, F.; Romero, D.; Abdelmalek, M.F.; Anstee, Q.M.; Arab, J.P.; et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023, 78, 1966–1986. [Google Scholar] [CrossRef]
- Rajewski, P.; Cieściński, J.; Rajewski, P. Use of Fibroscan Liver Elastography in the Rapid Diagnosis and Monitoring of MASLD Treatment. Ann. Case Rep. 2024, 9, 2129. [Google Scholar] [CrossRef]
- Adler, N.E.; Glymour, M.M.; Fielding, J. Addressing Social Determinants of Health and Health Inequalities. JAMA 2016, 316, 1641–1642. [Google Scholar] [CrossRef]
- Ochoa-Allemant, P.; Marrero, J.A.; Serper, M. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. Hepatol. Commun. 2023, 7, e0324. [Google Scholar] [CrossRef]
- Díaz, L.A.; Lazarus, J.V.; Fuentes-López, E.; Idalsoaga, F.; Ayares, G.; Desaleng, H.; Danpanichkul, P.; Cotter, T.G.; Dunn, W.; Barrera, F.; et al. Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria. Commun. Med. 2024, 4, 219. [Google Scholar] [CrossRef]
- Semega, J.; Kollar, M.; Creamer, J.; Mohanty, A. Income and Poverty in the United States: 2018; United States Census Bureau, Ed.; U.S. Government Printing Office: Washington, DC, USA, 2019; pp. 60–266.
- Czapla, B.C.; Dalvi, A.; Hu, J.; Moran, I.J.; Wijarnpreecha, K.; Chen, V.L. Physical activity, diet, and social determinants of health associate with health related quality of life and fibrosis in MASLD. Sci. Rep. 2025, 15, 7976. [Google Scholar] [CrossRef] [PubMed]
- Vilar-Gomez, E.; Nephew, L.D.; Vuppalanchi, R.; Gawrieh, S.; Mladenovic, A.; Pike, F.; Samala, N.; Chalasani, N. High-quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population. Hepatology 2022, 75, 1491–1506. [Google Scholar] [CrossRef] [PubMed]
- Tesfai, K.; Pace, J.; El-Newihi, N.; Martinez, M.E.; Tincopa, M.A.; Loomba, R. Disparities for Hispanic Adults With Metabolic Dysfunction-associated Steatotic Liver Disease in the United States: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol. 2025, 23, 236–249. [Google Scholar] [CrossRef] [PubMed]
- Lin, X.; Bao, S.; Yu, Y.; Huang, H.; Shu, M. Self-management in patients with metabolic dysfunction-associated steatotic liver disease: Influencing factors and impact on readmission. J. Health Popul. Nutr. 2024, 43, 134. [Google Scholar] [CrossRef]
- Miller, K.C.; Geyer, B.; Alexopoulos, A.-S.; Moylan, C.A.; Pagidipati, N. Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review. Dig. Dis. Sci. 2025, 70, 154–167. [Google Scholar] [CrossRef]
- Lam, E.; Partridge, S.R.; Allman-Farinelli, M. Strategies for successful recruitment of young adults to healthy lifestyle programmes for the prevention of weight gain: A systematic review. Obes. Rev. 2016, 17, 178–200. [Google Scholar] [CrossRef]
- Hiza, H.A.; Casavale, K.O.; Guenther, P.M.; Davis, C.A. Diet quality of Americans differs by age, sex, race/ethnicity, income, and education level. J. Acad. Nutr. Diet. 2013, 113, 297–306. [Google Scholar] [CrossRef]
- Zhang, X.; Daniel, C.R.; Soltero, V.; Vargas, X.; Jain, S.; Kanwal, F.; Thrift, A.P.; Balakrishnan, M. A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients. Off. J. Am. Coll. Gastroenterol. ACG 2024, 119, 505–511. [Google Scholar] [CrossRef]
- Hassani Zadeh, S.; Mansoori, A.; Hosseinzadeh, M. Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J. Gastroenterol. Hepatol. 2021, 36, 1470–1478. [Google Scholar] [CrossRef] [PubMed]
- Lin, X.; Wang, S.; Huang, J. The effects of time-restricted eating for patients with nonalcoholic fatty liver disease: A systematic review. Front. Nutr. 2024, 10, 1307736. [Google Scholar] [CrossRef] [PubMed]
- Niezen, S.A.-O.; Goyes, D.; Vipani, A.A.-O.X.; Yang, J.D.; Ayoub, W.A.-O.; Kuo, A.A.-O.; Long, M.T.; Trivedi, H.A.-O. Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study. J. Clin. Med. 2024, 13, 3206. [Google Scholar] [CrossRef] [PubMed]
- Matthews, K.A.; Räikkönen, K.; Gallo, L.; Kuller, L.H. Association between socioeconomic status and metabolic syndrome in women: Testing the reserve capacity model. Health Psychol. 2008, 27, 576–583. [Google Scholar] [CrossRef]
- Dallongeville, J.; Cottel, D.; Ferrières, J.; Arveiler, D.; Bingham, A.; Ruidavets, J.B.; Haas, B.; Ducimetière, P.; Amouyel, P. Household Income Is Associated With the Risk of Metabolic Syndrome in a Sex-Specific Manner. Diabetes Care 2005, 28, 409–415. [Google Scholar] [CrossRef]
- Marmot, M. The Influence Of Income On Health: Views Of An Epidemiologist. Health Aff. 2002, 21, 31–46. [Google Scholar] [CrossRef]
- Li, M. Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017–2020. Wien. Klin. Wochenschr. 2024, 136, 258–266. [Google Scholar] [CrossRef]
- Mambrini, S.P.; Grillo, A.; Colosimo, S.; Zarpellon, F.; Pozzi, G.; Furlan, D.; Amodeo, G.; Bertoli, S. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front. Nutr. 2024, 11, 1426551. [Google Scholar] [CrossRef]
- Romeo, S.; Kozlitina, J.; Xing, C.; Pertsemlidis, A.; Cox, D.; Pennacchio, L.A.; Boerwinkle, E.; Cohen, J.C.; Hobbs, H.H. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 2008, 40, 1461–1465. [Google Scholar] [CrossRef]
- Alhomaid, A.; Chauhan, S.; Katamreddy, Y.; Sidhu, A.; Sunkara, P.; Desai, R. Prevalence and association of MASLD in metabolically healthy young Asian Americans with obesity: A nationwide inpatient perspective (2019). Obes. Pillars 2025, 13, 100168. [Google Scholar] [CrossRef]
- Zhu, L.A.-O.; Yang, W.J.; Spence, C.A.-O.; Bhimla, A.; Ma, G.X. Lean Yet Unhealthy: Asian American Adults Had Higher Risks for Metabolic Syndrome than Non-Hispanic White Adults with the Same Body Mass Index: Evidence from NHANES 2011–2016. Healthcare 2021, 9, 1518. [Google Scholar] [CrossRef]
- Fan, J.-G.; Kim, S.-U.; Wong, V.W.-S. New trends on obesity and NAFLD in Asia. J. Hepatol. 2017, 67, 862–873. [Google Scholar] [CrossRef]
- Motamed, N.; Maadi, M.; Sohrabi, M.; Keyvani, H.; Poustchi, H.; Zamani, F. Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD. Hepat. Mon. 2016, 16, e38357. [Google Scholar] [CrossRef]
- Nikolic Turnic, T.; Jakovljevic, V.; Strizhkova, Z.; Polukhin, N.; Ryaboy, D.; Kartashova, M.; Korenkova, M.; Kolchina, V.; Reshetnikov, V. The Association between Marital Status and Obesity: A Systematic Review and Meta-Analysis. Diseases 2024, 12, 146. [Google Scholar] [CrossRef]
- Nakaya, N.; Xie, T.; Scheerder, B.; Tsuchiya, N.; Narita, A.; Nakamura, T.; Metoki, H.; Obara, T.; Ishikuro, M.; Hozawa, A.; et al. Spousal similarities in cardiometabolic risk factors: A cross-sectional comparison between Dutch and Japanese data from two large biobank studies. Atherosclerosis 2021, 334, 85–92. [Google Scholar] [CrossRef]
All Participants | Non-MASLD | MASLD | p Value * | |
---|---|---|---|---|
Total [n] | 3202 | 1310 | 1892 | |
Male [n (%)] | 1644 (51.3) | 607 (46.3) | 1037 (54.8) | <0.001 |
Race/Ethnicity [n (%)] | <0.001 | |||
Non-Hispanic White | 1239 (38.7) | 507 (38.7) | 732 (38.7) | |
Mexican American | 436 (13.6) | 124 (9.5) | 312 (16.5) | |
Other Hispanic | 269 (8.4) | 103 (7.9) | 166 (8.8) | |
Non-Hispanic Black | 722 (22.5) | 349 (26.6) | 373 (19.7) | |
Non-Hispanic Asian | 356 (11.1) | 150 (11.5) | 206 (10.9) | |
Other Race/Multi-Racial | 180 (5.6) | 77 (5.9) | 103 (5.4) | |
Age [Mean (SD)] | 50.6 (17.2) | 47.0 (18.3) | 53.2 (15.9) | <0.001 |
BMI [Mean (SD)] | 29.9 (7.2) | 26.01 (5.3) | 32.61 (7.0) | <0.001 |
BMI Category (kg/m2) [n (%)] | <0.001 | |||
<18.5 | 756 (23.6) | 580 (44.3) | 176 (9.3) | |
18.5–24.9 | 38 (1.2) | 35 (2.7) | 3 (0.2) | |
25–29.9 | 1023 (31.9) | 427 (32.6) | 596 (31.5) | |
≥30 | 1385 (43.3) | 268 (20.5) | 1117 (59.0) | |
Comorbidities [n (%)] | ||||
Hypertension | 1208 (37.7) | 341 (26.0) | 867 (45.8) | <0.001 |
Hypercholesterolemia | 1169 (36.5) | 374 (28.5) | 795 (42.0) | <0.001 |
Diabetes | 475 (14.8) | 93 (7.1) | 382 (20.2) | <0.001 |
Steatosis Grade [n (%)] | <0.001 | |||
S0 | 1276 (39.9) | 1276 (97.4) | 0 (0.0) | |
S1 | 321 (10.0) | 16 (1.2) | 305 (16.1) | |
S2 | 239 (7.5) | 3 (0.2) | 236 (12.5) | |
S3 | 1366 (42.7) | 15 (1.1) | 1351 (71.4) | |
Fibrosis Grade [n (%)] | <0.001 | |||
F0 to F1 | 2638 (82.4) | 1194 (91.1) | 1444 (76.3) | |
F2 | 337 (10.5) | 83 (6.3) | 254 (13.4) | |
F3 | 124 (3.9) | 16 (1.2) | 108 (5.7) | |
F4 | 103 (3.2) | 17 (1.3) | 86 (4.5) | |
History of Hepatitis B [n (%)] | 33 (1.0) | 12 (0.9) | 21 (1.1) | 0.70 |
History of Hepatitis C [n (%)] | 64 (2.0) | 33 (2.5) | 31 (1.6) | 0.10 |
Alcohol Use [n (%)] | 0.20 | |||
Never drink | 724 (22.6) | 275 (21.0) | 449 (23.7) | |
Drink daily | 220 (6.9) | 91 (6.9) | 129 (6.8) | |
Drink few times/week | 692 (21.6) | 289 (22.1) | 403 (21.3) | |
Drink few times/month | 665 (20.8) | 293 (22.4) | 372 (19.7) | |
Drink few times/year | 901 (28.1) | 362 (27.6) | 539 (28.5) |
All Participants | Non-MASLD | MASLD | p Value * | |
---|---|---|---|---|
Total [n] | 3202 | 1310 | 1892 | |
Income Level [n (%)] | 0.69 | |||
<$65,000 | 1987 (62.1) | 807 (61.6) | 1180 (62.4) | |
≥65,000 | 1215 (37.9) | 503 (38.4) | 712 (37.6) | |
Education Level [n (%)] | <0.001 | |||
Less than college | 2414 (75.4) | 440 (72.1) | 759 (77.8) | |
College graduate or above | 788 (24.6) | 367 (27.9) | 421 (22.2) | |
Marital Status [n (%)] | <0.001 | |||
Single, widowed, never married, and/or separated | 1297 (40.5) | 596 (45.5) | 701 (37.1) | |
Married or living with partner | 1905 (59.5) | 714 (54.5) | 1191 (62.9) | |
Achieving Moderate Physical Recreational Activity [n (%)] | 818 (25.5) | 437 (33.2) | 381 (20.1) | <0.001 |
Food Security [n (%)] | 0.043 | |||
Marginal or low food security | 1165 (36.3) | 449 (34.3) | 716 (37.8) | |
Full food security | 2037 (63.7) | 861 (65.7) | 1176 (62.2) | |
Access to Healthcare Facility [n (%)] | 2593 (81.0) | 1017 (77.6) | 1576 (83.3) | <0.001 |
Private Insurance [n (%)] | 1658 (51.8) | 659 (50.3) | 999 (52.8) | 0.18 |
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p Value | OR | 95% CI | p Value | |
Education | ||||||
Less than college | Ref | |||||
College or above | 0.74 | 0.63, 0.86 | <0.001 | 0.77 | 0.62, 0.97 | 0.024 |
Income | ||||||
<65,000 | Ref | |||||
≥$65,000 | 0.97 | 0.84, 1.12 | 0.70 | 1.12 | 0.91, 1.37 | 0.3 |
Age | 1.02 | 1.02, 1.03 | <0.001 | 1.02 | 1.01, 1.03 | <0.001 |
Male | 1.4 | 1.22, 1.62 | <0.001 | 1.42 | 1.19, 1.70 | <0.001 |
Race/Ethnicity | ||||||
Non-Hispanic White | Ref | |||||
Mexican American | 1.74 | 1.38, 2.21 | <0.001 | 1.71 | 1.29, 2.28 | <0.001 |
Other Hispanic | 1.12 | 0.85, 1.47 | 0.40 | 1.08 | 0.79, 1.49 | 0.6 |
Non-Hispanic Black | 0.74 | 0.62, 0.89 | 0.001 | 0.63 | 0.50, 0.79 | <0.001 |
Non-Hispanic Asian | 0.95 | 0.75, 1.21 | 0.70 | 2.37 | 1.75, 3.23 | <0.001 |
Other race | 0.93 | 0.68, 1.27 | 0.60 | 1 | 0.69, 1.47 | >0.9 |
Hypertension History | 2.4 | 2.06, 2.80 | <0.001 | 1.33 | 1.09, 1.62 | 0.006 |
Diabetes History | 3.31 | 2.62, 4.22 | <0.001 | 1.69 | 1.28, 2.25 | <0.001 |
Hypercholesterolemia History | 1.81 | 1.56, 2.11 | <0.001 | 1.08 | 0.89, 1.32 | 0.4 |
BMI Category | ||||||
18.5–24.9 | Ref | |||||
<18.5 | 0.28 | 0.07, 0.80 | 0.037 | 0.4 | 0.10, 1.17 | 0.14 |
25–29.9 | 4.6 | 3.74, 5.68 | <0.001 | 4.33 | 3.46, 5.46 | <0.001 |
≥30 | 13.7 | 11.1, 17.1 | <0.001 | 16.6 | 13.1, 21.3 | <0.001 |
History of Hepatitis B | 1.21 | 0.60, 2.55 | 0.60 | 0.93 | 0.41, 2.18 | 0.90 |
History of Hepatitis C | 0.64 | 0.39, 1.06 | 0.08 | 0.57 | 0.31, 1.03 | 0.06 |
Alcohol Use | ||||||
Never drink | Ref | |||||
Drink daily | 0.87 | 0.64, 1.18 | 0.40 | 1.53 | 1.05, 2.23 | 0.026 |
Drink few times/week | 0.85 | 0.69, 1.06 | 0.15 | 1.26 | 0.96, 1.64 | 0.09 |
Drink few times/month | 0.78 | 0.63, 0.96 | 0.021 | 0.98 | 0.75, 1.28 | 0.90 |
Drink few times/year | 0.91 | 0.75, 1.11 | 0.40 | 1.05 | 0.82, 1.34 | 0.70 |
Achieving Moderate Physical activity | 0.5 | 0.43, 0.59 | <0.001 | 0.72 | 0.59, 0.89 | 0.002 |
Full Food Security | 0.86 | 0.74, 0.99 | 0.039 | 0.76 | 0.63, 0.93 | 0.007 |
Private Insurance | 1.11 | 0.96, 1.27 | 0.20 | 1.19 | 0.99, 1.44 | 0.06 |
Access to Healthcare | 1.44 | 1.20, 1.72 | <0.001 | 1.01 | 0.80, 1.27 | 0.90 |
Married/Living with Partner | 1.42 | 1.23, 1.64 | <0.001 | 1.28 | 1.07, 1.53 | 0.008 |
Food-Secure Stratum | Food-Insecure Stratum | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p Value | OR | 95% CI | p Value | |
Education | ||||||
<College | Ref | Ref | ||||
College or above | 0.71 | 0.55, 0.91 | 0.007 | 1.26 | 0.76, 2.11 | 0.40 |
Age | 1.02 | 1.01, 1.03 | <0.001 | 1.02 | 1.01, 1.04 | <0.001 |
Male | 1.55 | 1.24, 1.93 | <0.001 | 1.2 | 0.88, 1.64 | 0.30 |
Race/Ethnicity | ||||||
Non-Hispanic White | Ref | Ref | ||||
Mexican American | 1.83 | 1.26, 2.68 | 0.002 | 1.54 | 0.98, 2.44 | 0.06 |
Other Hispanic | 0.99 | 0.65, 1.51 | >0.90 | 1.11 | 0.67, 1.86 | 0.70 |
Non-Hispanic Black | 0.72 | 0.54, 0.97 | 0.028 | 0.47 | 0.32, 0.69 | <0.001 |
Non-Hispanic Asian | 2.24 | 1.58, 3.19 | <0.001 | 2.98 | 1.56, 5.86 | 0.001 |
Other race | 1.05 | 0.64, 1.74 | 0.80 | 0.95 | 0.52, 1.76 | 0.90 |
Hypertension History | 1.23 | 0.96, 1.58 | 0.10 | 1.57 | 1.10, 2.23 | 0.012 |
Diabetes History | 1.96 | 1.38, 2.84 | <0.001 | 1.22 | 0.77, 1.95 | 0.40 |
Hypercholesterolemia History | 1.02 | 0.80, 1.29 | 0.90 | 1.2 | 0.85, 1.72 | 0.30 |
BMI Category | ||||||
18.5–24.9 | Ref | Ref | ||||
<18.5 | 0.42 | 0.07, 1.55 | 0.30 | 0.38 | 0.02, 2.05 | 0.40 |
25–29.9 | 3.89 | 2.95, 5.17 | <0.001 | 5.63 | 3.77, 8.53 | <0.001 |
≥30 | 15.7 | 11.6, 21.5 | <0.001 | 19.8 | 13.1, 30.4 | <0.001 |
History of Hepatitis B | 1.33 | 0.49, 4.07 | 0.60 | 0.46 | 0.09, 2.16 | 0.30 |
History of Hepatitis C | 0.72 | 0.30, 1.70 | 0.50 | 0.45 | 0.19, 1.09 | 0.07 |
Alcohol Use | ||||||
Never drink | Ref | Ref | ||||
Drink daily | 1.77 | 1.12, 2.83 | 0.015 | 1.21 | 0.63, 2.35 | 0.60 |
Drink few times/week | 1.12 | 0.80, 1.56 | 0.50 | 1.62 | 1.02, 2.59 | 0.042 |
Drink few times/month | 0.86 | 0.61, 1.20 | 0.40 | 1.23 | 0.79, 1.93 | 0.40 |
Drink few times/year | 1.04 | 0.76, 1.42 | 0.80 | 1.01 | 0.68, 1.51 | >0.9 |
Achieving Moderate Physical Activity | 0.68 | 0.53, 0.87 | 0.002 | 0.86 | 0.58, 1.27 | 0.40 |
Private Insurance | 1.18 | 0.93, 1.48 | 0.20 | 1.21 | 0.87, 1.69 | 0.30 |
Access to Healthcare | 0.9 | 0.66, 1.22 | 0.50 | 1.14 | 0.79, 1.62 | 0.50 |
Married/Living with Partner | 1.42 | 1.13, 1.79 | 0.003 | 1.16 | 0.86, 1.56 | 0.30 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Singh, V.; Cheng, S.; Velazquez, A.; Trivedi, H.D.; Kwan, A.C. The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States. J. Clin. Med. 2025, 14, 5484. https://doi.org/10.3390/jcm14155484
Singh V, Cheng S, Velazquez A, Trivedi HD, Kwan AC. The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States. Journal of Clinical Medicine. 2025; 14(15):5484. https://doi.org/10.3390/jcm14155484
Chicago/Turabian StyleSingh, Vidhi, Susan Cheng, Amanda Velazquez, Hirsh D. Trivedi, and Alan C. Kwan. 2025. "The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States" Journal of Clinical Medicine 14, no. 15: 5484. https://doi.org/10.3390/jcm14155484
APA StyleSingh, V., Cheng, S., Velazquez, A., Trivedi, H. D., & Kwan, A. C. (2025). The Impact of Social Determinants of Health on Metabolic Dysfunction-Associated Steatotic Liver Disease Among Adults in the United States. Journal of Clinical Medicine, 14(15), 5484. https://doi.org/10.3390/jcm14155484